LAMEA Inflammatory Bowel Disease Treatment Market By Type (Crohn's Disease and Ulcerative Colitis), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), By Route of Administration (Injectable and Oral), By Drug Class (TNF inhibitors, Anti-integrin, IL inhibitors, Corticosteroids, JAK inhibitors, Aminosalicylates and Others), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

The Latin America, Middle East and Africa Inflammatory Bowel Disease Treatment Market would witness market growth of 12.5% CAGR during the forecast period (2021-2027).

Sometimes, people suffering from inflammatory bowel disease have active lifestyle. However, the symptoms of ulcerative colitis and Crohn’s disease disrupt life. Many people opt for surgery as an option to cure the disease whereas some people take medications and go into remission. The healthcare providers also recommend some of the changes in the lifestyle and diet to control inflammatory bowel disease.

Further, biosimilars like Renflexis, Hyrimoz, Inflectra, and Imraldi are increasingly receiving approvals that are anticipated to fuel the adoption of efficacious treatment as it offers several benefits in comparison to the conventional treatment options. Additionally, biosimilar products such as Hulio, IXIFI, Cyltezo, and Avsola have also received approval and are also anticipated to gain traction and receive high demand in the coming years. Thus, the demand for biosimilars would rise in developing nations. Moreover, the biosimilars that are used for pediatric Crohn’s disease are increasingly receiving approvals, which will support the growth of the market across the world.

The inflammatory bowel disease treatment market is likely to grow at a moderate pace in LAMEA. The factors contributing to the growth of the regional market are the prevalence of anxiety & depression, advancements in medical technology, government support for inflammatory bowel disease treatment research, and the growing prevalence of Crohn's Disease and Ulcerative Colitis. Additionally, the unhealthy lifestyle of people, increase in alcohol consumption and cigarette smoking, and irregular food habits are other factors supporting the growth of the market.

Moreover, the growing popularity of prebiotic and probiotic foods, rise in investments in building a robust pipeline for IBD, and increase in lifestyle-related risk factors would accelerate the growth of the market in the upcoming years. Further, the increase in the expenditure in the healthcare sector in the region, growing geriatric population base, and increasing prevalence of Crohn's disease and Ulcerative Colitis are also contributing to the growth of the regional inflammatory bowel disease treatment market in the forthcoming years.

The Brazil market dominated the LAMEA Ulcerative Colitis Market by Country 2020, thereby, achieving a market value of $206 million by 2027. The Argentina market would witness a CAGR of 13.9% during (2021 - 2027). Additionally, The UAE market is expected to witness a CAGR of 13.2% during (2021 - 2027).

Based on Type, the market is segmented into Crohn's Disease and Ulcerative Colitis. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on Route of Administration, the market is segmented into Injectable and Oral. Based on Drug Class, the market is segmented into TNF inhibitors, Anti-integrin, IL inhibitors, Corticosteroids, JAK inhibitors, Aminosalicylates and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Inflammatory Bowel Disease Treatment Market is Predict to reach $29.2 Billion by 2027, at a CAGR of 8.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC (AbbVie), Johnson & Johnson, Merck Group, Amgen, Inc., Eli Lilly and Company, Biogen, Inc., Pfizer, Inc., Novartis AG, Takeda Pharmaceutical Company Limited, and UCB S.A.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Crohn's Disease and
• Ulcerative Colitis

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Route of Administration

• Injectable
• Oral

By Drug Class

• TNF inhibitors
• Anti-integrin
• IL inhibitors
• Corticosteroids
• JAK inhibitors
• Aminosalicylates
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Allergan PLC (AbbVie)
• Johnson & Johnson
• Merck Group
• Amgen, Inc.
• Eli Lilly and Company
• Biogen, Inc.
• Pfizer, Inc.
• Novartis AG
• Takeda Pharmaceutical Company Limited
• UCB S.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Inflammatory Bowel Disease Treatment Market, by Type
1.4.2 LAMEA Inflammatory Bowel Disease Treatment Market, by Distribution Channel
1.4.3 LAMEA Inflammatory Bowel Disease Treatment Market, by Route of Administration
1.4.4 LAMEA Inflammatory Bowel Disease Treatment Market, by Drug Class
1.4.5 LAMEA Inflammatory Bowel Disease Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Approvals and Trials : 2017, Aug – 2021, Sep) Leading Players

Chapter 4. LAMEA Inflammatory Bowel Disease Treatment Market by Type
4.1 LAMEA Crohn's Disease Market by Country
4.2 LAMEA Ulcerative Colitis Market by Country

Chapter 5. LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel
5.1 LAMEA Hospital Pharmacy Market by Country
5.2 LAMEA Retail Pharmacy Market by Country
5.3 LAMEA Online Pharmacy Market by Country

Chapter 6. LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration
6.1 LAMEA Injectable Market by Country
6.2 LAMEA Oral Market by Country

Chapter 7. LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class
7.1 LAMEA TNF inhibitors Market by Country
7.2 LAMEA Anti-integrin Market by Country
7.3 LAMEA IL inhibitors Market by Country
7.4 LAMEA Corticosteroids Market by Country
7.5 LAMEA JAK inhibitors Market by Country
7.6 LAMEA Aminosalicylates Market by Country
7.7 LAMEA Others Market by Country

Chapter 8. LAMEA Inflammatory Bowel Disease Treatment Market by Country
8.1 Brazil Inflammatory Bowel Disease Treatment Market
8.1.1 Brazil Inflammatory Bowel Disease Treatment Market by Type
8.1.2 Brazil Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.1.3 Brazil Inflammatory Bowel Disease Treatment Market by Route of Administration
8.1.4 Brazil Inflammatory Bowel Disease Treatment Market by Drug Class
8.2 Argentina Inflammatory Bowel Disease Treatment Market
8.2.1 Argentina Inflammatory Bowel Disease Treatment Market by Type
8.2.2 Argentina Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.2.3 Argentina Inflammatory Bowel Disease Treatment Market by Route of Administration
8.2.4 Argentina Inflammatory Bowel Disease Treatment Market by Drug Class
8.3 UAE Inflammatory Bowel Disease Treatment Market
8.3.1 UAE Inflammatory Bowel Disease Treatment Market by Type
8.3.2 UAE Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.3.3 UAE Inflammatory Bowel Disease Treatment Market by Route of Administration
8.3.4 UAE Inflammatory Bowel Disease Treatment Market by Drug Class
8.4 Saudi Arabia Inflammatory Bowel Disease Treatment Market
8.4.1 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Type
8.4.2 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.4.3 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Route of Administration
8.4.4 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Drug Class
8.5 South Africa Inflammatory Bowel Disease Treatment Market
8.5.1 South Africa Inflammatory Bowel Disease Treatment Market by Type
8.5.2 South Africa Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.5.3 South Africa Inflammatory Bowel Disease Treatment Market by Route of Administration
8.5.4 South Africa Inflammatory Bowel Disease Treatment Market by Drug Class
8.6 Nigeria Inflammatory Bowel Disease Treatment Market
8.6.1 Nigeria Inflammatory Bowel Disease Treatment Market by Type
8.6.2 Nigeria Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.6.3 Nigeria Inflammatory Bowel Disease Treatment Market by Route of Administration
8.6.4 Nigeria Inflammatory Bowel Disease Treatment Market by Drug Class
8.7 Rest of LAMEA Inflammatory Bowel Disease Treatment Market
8.7.1 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Type
8.7.2 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.7.3 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration
8.7.4 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class

Chapter 9. Company Profiles
9.1 Allergan PLC (AbbVie)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Approvals and Trials:
9.2 Johnson & Johnson
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental &Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Approvals and Trials:
9.3 Merck Group
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Acquisitions and Mergers:
9.3.5.3 Product Launches and Product Expansions:
9.4 Amgen, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Acquisitions and Mergers:
9.4.5.3 Geographical Expansions:
9.4.5.4 Approvals and Trials:
9.5 Eli Lilly and Company
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.6 Biogen, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Approvals and Trials:
9.7 Pfizer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Acquisitions and Mergers:
9.7.5.2 Approvals and Trials:
9.8 Novartis AG
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisitions and Mergers:
9.8.5.3 Approvals and Trials:
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Acquisitions and Mergers:
9.9.5.3 Product Launches and Product Expansions:
9.9.5.4 Approvals and Trials:
9.10. UCB S.A.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Approvals and Trials:

TABLE 1 LAMEA Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Inflammatory Bowel Disease Treatment Market
TABLE 4 Product Launches And Product Expansions– Inflammatory Bowel Disease Treatment Market
TABLE 5 Acquisition and Mergers– Inflammatory Bowel Disease Treatment Market
TABLE 6 Geographical Expansions– Inflammatory Bowel Disease Treatment Market
TABLE 7 Approvals and TRials– Inflammatory Bowel Disease Treatment Market
TABLE 8 LAMEA Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 9 LAMEA Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 10 LAMEA Crohn's Disease Market by Country, 2017 - 2020, USD Million
TABLE 11 LAMEA Crohn's Disease Market by Country, 2021 - 2027, USD Million
TABLE 12 LAMEA Ulcerative Colitis Market by Country, 2017 - 2020, USD Million
TABLE 13 LAMEA Ulcerative Colitis Market by Country, 2021 - 2027, USD Million
TABLE 14 LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 15 LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 16 LAMEA Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 17 LAMEA Hospital Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 18 LAMEA Retail Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 19 LAMEA Retail Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 20 LAMEA Online Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 21 LAMEA Online Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 22 LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 23 LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 24 LAMEA Injectable Market by Country, 2017 - 2020, USD Million
TABLE 25 LAMEA Injectable Market by Country, 2021 - 2027, USD Million
TABLE 26 LAMEA Oral Market by Country, 2017 - 2020, USD Million
TABLE 27 LAMEA Oral Market by Country, 2021 - 2027, USD Million
TABLE 28 LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 29 LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 30 LAMEA TNF inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 31 LAMEA TNF inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 32 LAMEA Anti-integrin Market by Country, 2017 - 2020, USD Million
TABLE 33 LAMEA Anti-integrin Market by Country, 2021 - 2027, USD Million
TABLE 34 LAMEA IL inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 35 LAMEA IL inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 36 LAMEA Corticosteroids Market by Country, 2017 - 2020, USD Million
TABLE 37 LAMEA Corticosteroids Market by Country, 2021 - 2027, USD Million
TABLE 38 LAMEA JAK inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 39 LAMEA JAK inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 40 LAMEA Aminosalicylates Market by Country, 2017 - 2020, USD Million
TABLE 41 LAMEA Aminosalicylates Market by Country, 2021 - 2027, USD Million
TABLE 42 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 43 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 44 LAMEA Inflammatory Bowel Disease Treatment Market by Country, 2017 - 2020, USD Million
TABLE 45 LAMEA Inflammatory Bowel Disease Treatment Market by Country, 2021 - 2027, USD Million
TABLE 46 Brazil Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 47 Brazil Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 48 Brazil Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 49 Brazil Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 50 Brazil Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 51 Brazil Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 52 Brazil Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 53 Brazil Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 54 Brazil Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 55 Brazil Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 56 Argentina Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 57 Argentina Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 58 Argentina Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 59 Argentina Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 60 Argentina Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 61 Argentina Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 62 Argentina Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 63 Argentina Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 64 Argentina Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 65 Argentina Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 66 UAE Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 67 UAE Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 68 UAE Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 69 UAE Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 70 UAE Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 71 UAE Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 72 UAE Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 73 UAE Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 74 UAE Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 75 UAE Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 76 Saudi Arabia Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 77 Saudi Arabia Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 78 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 79 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 80 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 81 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 82 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 83 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 84 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 85 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 86 South Africa Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 87 South Africa Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 88 South Africa Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 89 South Africa Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 90 South Africa Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 91 South Africa Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 92 South Africa Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 93 South Africa Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 94 South Africa Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 95 South Africa Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 96 Nigeria Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 97 Nigeria Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 98 Nigeria Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 99 Nigeria Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 100 Nigeria Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 101 Nigeria Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 102 Nigeria Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 103 Nigeria Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 104 Nigeria Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 105 Nigeria Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 106 Rest of LAMEA Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 107 Rest of LAMEA Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 108 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 109 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 110 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 111 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 112 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 113 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 114 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 115 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 116 Key Information – Allergan PLC
TABLE 117 Key information –Johnson & Johnson
TABLE 118 key Information – Merck Group
TABLE 119 Key Information – Amgen, Inc.
TABLE 120 Key Information – Eli Lilly and Company
TABLE 121 Key Information – Biogen, Inc.
TABLE 122 Key Information – Pfizer, Inc.
TABLE 123 Key Information – Novartis AG
TABLE 124 Key Information – Takeda Pharmaceutical Company Limited
TABLE 125 Key Information – UCB S.A.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Approvals and Trials : 2017, Aug – 2021, Sep) Leading Players
FIG 5 Recent strategies and developments: Merck Group
FIG 6 Recent strategies and developments: Amgen, Inc.
FIG 7 Recent strategies and developments: Biogen, Inc.
FIG 8 Recent strategies and developments: Pfizer, Inc.
FIG 9 Recent strategies and developments: Novartis AG
FIG 10 Recent strategies and developments: Takeda Pharmaceutical Company Limited